Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Liangzhi Xie
Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma
Chinese Journal of Cancer Research
Cancer Research
Oncology
Related publications
Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes
PLoS ONE
Multidisciplinary
Treatment of Graves' Disease and Associated Ophthalmopathy With the Anti-Cd20 Monoclonal Antibody Rituximab: An Open Study
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
New Insights in Type I and II CD20 Antibody Mechanisms-Of-Action With a Panel of Novel CD20 Antibodies
British Journal of Haematology
Hematology
Do We Need Maintenance With Anti-Cd20 Antibody After First-Line Therapy for All Newly Diagnosed Follicular Lymphoma Patients?
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Safety and Efficacy of Ofatumumab, a Fully Human Monoclonal Anti-Cd20 Antibody, in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia: A Phase 1-2 Study
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Clinical Activity of Regn1979, an Anti-Cd20 X Anti-Cd3 Bispecific Antibody (Ab) in Patients (Pts) With (W/) Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Secondary Antibody Deficiency: A Complication of Anti-Cd20 Therapy for Neuroinflammation
Journal of Neurology
Neurology
